{"@context":{"obo_purl":"http://purl.obolibrary.org/obo/","rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","owl":"http://www.w3.org/2002/07/owl#","rdfs":"http://www.w3.org/2000/01/rdf-schema#","skos":"http://www.w3.org/2004/02/skos/core#","oboinowl_gen":"http://www.geneontology.org/formats/oboInOwl#","ns0":"http://purl.obolibrary.org/obo/chebi#","metadata_def":"http://data.bioontology.org/metadata/def/","ns1":"http://purl.obolibrary.org/obo#"},"@graph":[{"@id":"obo_purl:CHEBI_38070","@type":"owl:Class","rdfs:subClassOf":{"@id":"obo_purl:CHEBI_35554"},"rdfs:label":"anti-arrhythmia drug","skos:notation":"CHEBI:38070","obo_purl:IAO_0000115":"A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres.","oboinowl_gen:hasOBONamespace":"chebi_ontology","oboinowl_gen:id":"CHEBI:38070","oboinowl_gen:inSubset":{"@id":"ns0:3_STAR"},"metadata_def:prefLabel":"anti-arrhythmia drug","oboinowl_gen:hasRelatedSynonym":["anti-arrhythmia agent","antiarrhythmic agent"],"metadata_def:mappingLoom":"antiarrhythmiadrug","metadata_def:mappingSameURI":{"@id":"obo_purl:CHEBI_38070"}},{"@id":"obo_purl:CHEBI_9948","ns1:has_role":{"@id":"obo_purl:CHEBI_38070"}}]}